Skip to main content
Erschienen in: Archives of Dermatological Research 9/2013

01.11.2013 | Short Communication

Stress and melanoma: increasing the evidence towards a causal basis

verfasst von: Sudipta Sinnya, Brian De’Ambrosis

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Melanoma is a multifactorial disease with a strong genetic component and known risk factors such as excessive ultraviolet exposure, intermittent sunburns and fair skin type. The prognosis is poor if diagnosis is delayed, in spite of recent treatment advances. Evidence is mounting that the incidence of melanoma is higher in the immunosuppressed and individuals with highly stressful occupations. We present a case series of individuals diagnosed with multiple cutaneous melanomas over a few months to 1 year. All had encountered psychological stressors in their lives, and the melanomas were diagnosed briefly after encountering these stressors. No known causes of immunosuppression were detected to explain the sporadic occurrence of melanomas in these individuals. There is evidence in the current literature that stress can lead to immune disregulation, predisposing an individual to various disease states including melanoma. Stress hormones such as norepinephrine have been shown to cause upregulation of cytokines such as Interleukin 6 and 8, which are proangiogenic and support tumour progression. Coupled with genetic and environmental factors, stress appears to play a role in melanoma formation and progression. Large prospective studies are required to study the link between stress and melanoma and gain further insight into the etiology of melanoma.
Literatur
2.
Zurück zum Zitat Duffy K, Grossman D (2012) The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic and clinical aspects. J Am Acad Dermatol. doi:10.1016/j.jaad.2012.03.013 Duffy K, Grossman D (2012) The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic and clinical aspects. J Am Acad Dermatol. doi:10.​1016/​j.​jaad.​2012.​03.​013
3.
Zurück zum Zitat Fagundes CP, Glaser R, Johnson SL et al (2012) Basal cell carcinoma stressful life events and the tumor environment basal cell carcinoma. Arch Gen Psychiatry 69:618–626PubMedCrossRef Fagundes CP, Glaser R, Johnson SL et al (2012) Basal cell carcinoma stressful life events and the tumor environment basal cell carcinoma. Arch Gen Psychiatry 69:618–626PubMedCrossRef
4.
Zurück zum Zitat Goymer P (2006) Tumorigenesis: stress and cancer. Nat Rev Cancer 6:658–659CrossRef Goymer P (2006) Tumorigenesis: stress and cancer. Nat Rev Cancer 6:658–659CrossRef
5.
6.
7.
Zurück zum Zitat Nilsson MB, Langley RR, Fidler IJ (2005) Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65:10794–10800PubMedCrossRef Nilsson MB, Langley RR, Fidler IJ (2005) Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65:10794–10800PubMedCrossRef
8.
Zurück zum Zitat Penninx BW, Guralnik JM, Pahor M et al (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888–1893PubMedCrossRef Penninx BW, Guralnik JM, Pahor M et al (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888–1893PubMedCrossRef
9.
Zurück zum Zitat Pfeifer GP, Besaratinia A (2012) UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci 11:90–97PubMedCrossRef Pfeifer GP, Besaratinia A (2012) UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci 11:90–97PubMedCrossRef
10.
Zurück zum Zitat Rahe RH, Meyer M, Smith M et al (1964) Social stress and illness onset. J Psychosom Res 8:35–44CrossRef Rahe RH, Meyer M, Smith M et al (1964) Social stress and illness onset. J Psychosom Res 8:35–44CrossRef
11.
Zurück zum Zitat Reiche EMV, Morimoto HK, Nunes SMV (2005) Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 17:515–527PubMedCrossRef Reiche EMV, Morimoto HK, Nunes SMV (2005) Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 17:515–527PubMedCrossRef
13.
14.
Zurück zum Zitat Simonetti O, Lucarini G, Brancorsini D et al (2002) Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 95:1963–1970PubMedCrossRef Simonetti O, Lucarini G, Brancorsini D et al (2002) Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 95:1963–1970PubMedCrossRef
15.
Zurück zum Zitat Scarparo AC, Sumida DH, Patrao MT et al (2004) Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. Arch Dermatol Res 296(3):112–119 Scarparo AC, Sumida DH, Patrao MT et al (2004) Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. Arch Dermatol Res 296(3):112–119
16.
Zurück zum Zitat Yang EV, Kim SJ, Donovan EL et al (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23:267–275PubMedCrossRef Yang EV, Kim SJ, Donovan EL et al (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23:267–275PubMedCrossRef
Metadaten
Titel
Stress and melanoma: increasing the evidence towards a causal basis
verfasst von
Sudipta Sinnya
Brian De’Ambrosis
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2013
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-013-1373-2

Weitere Artikel der Ausgabe 9/2013

Archives of Dermatological Research 9/2013 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.